Insider · CIK 0001170542

TANEN DAVID M

Reports to the SEC for 6 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001170542

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34K sh	—	—	0
2025-06-20	Kronos Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−363K sh	$0.57	−$207K	0
2025-06-20	Kronos Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−471K sh	$0.57	−$269K	0
2025-06-20	Kronos Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−26.4K sh	$0.57	−$15K	0
2025-06-20	Kronos Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−26.4K sh	$0.57	−$15K	0
2025-06-20	Kronos Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−26.4K sh	$0.57	−$15K	0
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−85.6K sh	—	—	0
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.9K sh	—	—	0
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.6K sh	—	—	0
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34K sh	—	—	0
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34K sh	—	—	0
2024-06-25	Kronos Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2023-06-22	Kronos Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2022-06-22	Kronos Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2021-06-22	Kronos Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20.6K sh	—	—	20,600
2020-10-14	Kronos Bio, Inc.Series Seed Preferred StockC Conversion	Director	CConversion	−221K sh	—	—	0
2020-10-14	Kronos Bio, Inc.Convertible Promissory NoteC Conversion	Director	CConversion	—	—	—	0
2020-10-14	Kronos Bio, Inc.C Conversion	Director	CConversion	+37.1K sh	$16.15	+$599K	471,230
2020-10-14	Kronos Bio, Inc.Series Seed Preferred StockC Conversion	Director	CConversion	−219K sh	—	—	0
2020-10-14	Kronos Bio, Inc.Series A Preferred StockC Conversion	Director	CConversion	−65.2K sh	—	—	0
2020-10-14	Kronos Bio, Inc.C Conversion	Director	CConversion	+232K sh	—	—	363,428
2020-10-14	Kronos Bio, Inc.C Conversion	Director	CConversion	+233K sh	—	—	365,280
2020-10-14	Kronos Bio, Inc.C Conversion	Director	CConversion	+68.8K sh	—	—	434,111
2016-10-03	Arno Therapeutics, Inc2016 Series F Warrants (right to buy)P Purchase	Director, Secretary	PPurchase	+71.4K sh	—	—	71,428
2016-10-03	Arno Therapeutics, IncP Purchase	Director, Secretary	PPurchase	+143K sh	—	—	314,569
2016-04-07	Arno Therapeutics, IncStock Option (right to buy)A Award	Director, Secretary	AAward	+88.6K sh	—	—	88,628
2016-01-12	Arno Therapeutics, IncP Purchase	Director, Secretary	PPurchase	+362K sh	$0.35	+$127K	362,015
2014-01-24	Arno Therapeutics, IncStock Option (right to buy)A Award	Director, Secretary	AAward	+34.2K sh	—	—	34,224
2013-11-04	Arno Therapeutics, IncStock Option (right to buy)A Award	Director, Secretary	AAward	+68.4K sh	—	—	68,448
2009-09-24	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2009-09-24	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2009-09-24	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−65K sh	—	—	0
2009-09-24	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2009-09-24	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2009-09-24	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2009-07-21	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2009-07-15	CAPRCAPRICOR THERAPEUTICS, INC. · Warrant (Right to Buy)J Other	Director	JOther	+31.7K sh	—	—	31,650
2008-12-23	CAPRCAPRICOR THERAPEUTICS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2005-01-11	TGTXTG THERAPEUTICS, INC. · Director Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2003-10-28	VioQuest Pharmaceuticals, Inc.Stock OptionA Award	Director	AAward	+12.9K sh	—	—	12,900

Recent filings

Accepted (ET)
Jun 204
TANEN DAVID M0001415889-25-017829
SEC(opens sec.gov)
Jun 264
TANEN DAVID M0001415889-24-018224
SEC(opens sec.gov)
Jun 264
TANEN DAVID M0001209191-23-039684
SEC(opens sec.gov)
Jun 294
TANEN DAVID M0001209191-22-039775
SEC(opens sec.gov)
Jun 234
TANEN DAVID M0001209191-21-042877
SEC(opens sec.gov)
Oct 164
TANEN DAVID M0001209191-20-055044
SEC(opens sec.gov)

Companies

Address

C/O TWO RIVER GROUP HOLDINGS, LLC 689 FIFTH AVENUE, 12TH FLOOR

NEW YORK, NY, 10022